ADVERTISEMENT
Correction to: Same-Day Discharge After Elective Percutaneous Coronary Intervention for Chronic Total Occlusion in the UK
© 2024 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Journal of Invasive Cardiology or HMP Global, their employees, and affiliates.
J INVASIVE CARDIOL 2024. doi:10.25270/jic/21.00036.cx. Epub November 6, 2024.
This is a correction to the article: Taxiarchi P, Kontopantelis E, Kinnaird T, Curzen N, Ahmed J, Zaman A, Ludman P, Shoaib A, Martin GP, Mamas MA. Same-Day Discharge After Elective Percutaneous Coronary Intervention for Chronic Total Occlusion in the UK. J Invasive Cardiol. 2022 Mar;34(3):E179-E189. Epub January 28, 2022. doi: 10.25270/jic/21.00036.
In the originally published version of this manuscript, the funding information was inadvertently omitted. The following funding statement should be included: Funded by the North Staffordshire Medical Institute 50th Anniversary Award (Grant No. B890). The original version has been updated to reflect the change.
Affiliations and Disclosures
Paraskevi Taxiarchi, PhD1; Evangelos Kontopantelis, PhD2; Tim Kinnaird, MD3; Nick Curzen, PhD, FRCP, FESC4; Javed Ahmed, MBBS, FRCP, MD5; Azfar Zaman, BSc, MD, FRCP, MBChB5,6; Peter Ludman, MD7; Ahmad Shoaib, MD8; Glen P Martin, PhD2; Mamas A. Mamas, DPhil, BMBCh, MRCP, MD2,8
From the 1Centre for Biostatistics, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom; 2Division of Informatics, Imaging, and Data Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Center, Manchester, United Kingdom; 3University Hospital of Wales, Cardiff, United Kingdom; 4Coronary Research Group, University Hospital Southampton and Faculty of Medicine, University of Southampton, United Kingdom; 5Freeman Hospital, Newcastle, United Kingdom; 6Institute of Cellular Biology, Newcastle University; 7Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; and 8Keele Cardiovascular Research Group, Institute of Primary Care and Health Sciences, University of Keele and Academic Department of Cardiology, Royal Stoke Hospital, Stoke-on-Trent, United Kingdom.
Address for correspondence: Mamas A Mamas, DPhil, Keele Cardiovascular Research Group, Centre for Prognosis Research, Keele University, Stoke-on-Trent, United Kingdom. Email: mamasmamas1@yahoo.co.uk